Infectious Diseases (except HIV/AIDS)

  1. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2

    1. Raymond T Suhandynata
    2. Melissa A Hoffman
    3. Deli Huang
    4. Jenny T Tran
    5. Michael J Kelner
    6. Sharon L Reed
    7. Ronald W McLawhon
    8. James E Voss
    9. David Nemazee
    10. Robert L Fitzgerald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Dynamics of RT-qPCR SARS-CoV-2 Detection Rates Prior to and After Symptom Onset

    1. Scott Sherrill-Mix

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. The emergence of COVID-19 in Indonesia: analysis of predictors of infection and mortality using independent and clustered data approaches

    1. Erlina Burhan
    2. Ari Fahrial Syam
    3. Ahmad Jabir Rahyussalim
    4. Prasenohadi
    5. Navy G Lolong Wulung
    6. Agus Dwi Susanto
    7. I Gede Ketut Sajinadiyasa
    8. Dewi Puspitorini
    9. Dewi Lestari
    10. Indah Suci Widyahening
    11. Vivi Setiawaty
    12. Dwiana Ocviyanti
    13. Kartika Qonita Putri
    14. Aswin Guntara
    15. Davrina Rianda
    16. Anuraj H Shankar
    17. Rina Agustina

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population

    1. Ila Nimgaonkar
    2. Linda Valeri
    3. Ezra Susser
    4. Sabiha Hussain
    5. Jag Sunderram
    6. Abraham Aviv

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Neutralizing Antibody Responses in COVID-19 Convalescent Sera

    1. William T Lee
    2. Roxanne C Girardin
    3. Alan P Dupuis
    4. Karen E Kulas
    5. Anne F Payne
    6. Susan J Wong
    7. Suzanne Arinsburg
    8. Freddy T Nguyen
    9. Damodara Rao Mendu
    10. Adolfo Firpo-Betancourt
    11. Jeffrey Jhang
    12. Ania Wajnberg
    13. Florian Krammer
    14. Carlos Cordon-Cardo
    15. Sherlita Amler
    16. Marisa Montecalvo
    17. Brad Hutton
    18. Jill Taylor
    19. Kathleen A McDonough

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave

    1. Nicola Sweeney
    2. Blair Merrick
    3. Rui Pedro Galão
    4. Suzanne Pickering
    5. Alina Botgros
    6. Harry D. Wilson
    7. Adrian W. Signell
    8. Gilberto Betancor
    9. Mark Kia Ik Tan
    10. John Ramble
    11. Neophytos Kouphou
    12. Sam Acors
    13. Carl Graham
    14. Jeffrey Seow
    15. Eithne MacMahon
    16. Stuart J. D. Neil
    17. Michael H. Malim
    18. Katie Doores
    19. Sam Douthwaite
    20. Rahul Batra
    21. Gaia Nebbia
    22. Jonathan D. Edgeworth

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy

    1. Sara Conti
    2. Pietro Ferrara
    3. Giampiero Mazzaglia
    4. Marco I. D’Orso
    5. Roberta Ciampichini
    6. Carla Fornari
    7. Fabiana Madotto
    8. Michele Magoni
    9. Giuseppe Sampietro
    10. Andrea Silenzi
    11. Claudio V. Sileo
    12. Alberto Zucchi
    13. Giancarlo Cesana
    14. Lamberto Manzoli
    15. Lorenzo G. Mantovani

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The diagnostic accuracy of isothermal nucleic acid point-of-care tests for human coronaviruses: A systematic review and meta-analysis

    1. Pakpoom Subsoontorn
    2. Manupat Lohitnavy
    3. Chuenjid Kongkaew

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects

    1. Elena Criscuolo
    2. Roberta A. Diotti
    3. Marta Strollo
    4. Serena Rolla
    5. Alessandro Ambrosi
    6. Massimo Locatelli
    7. Roberto Burioni
    8. Nicasio Mancini
    9. Massimo Clementi
    10. Nicola Clementi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Natural killer cell immunotypes related to COVID-19 disease severity

    1. Christopher Maucourant
    2. Iva Filipovic
    3. Andrea Ponzetta
    4. Soo Aleman
    5. Martin Cornillet
    6. Laura Hertwig
    7. Benedikt Strunz
    8. Antonio Lentini
    9. Björn Reinius
    10. Demi Brownlie
    11. Angelica Cuapio
    12. Eivind Heggernes Ask
    13. Ryan M. Hull
    14. Alvaro Haroun-Izquierdo
    15. Marie Schaffer
    16. Jonas Klingström
    17. Elin Folkesson
    18. Marcus Buggert
    19. Johan K. Sandberg
    20. Lars I. Eriksson
    21. Olav Rooyackers
    22. Hans-Gustaf Ljunggren
    23. Karl-Johan Malmberg
    24. Jakob Michaëlsson
    25. Nicole Marquardt
    26. Quirin Hammer
    27. Kristoffer Strålin
    28. Niklas K. Björkström
    29. The Karolinska COVID-19 Study Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 21 of 716 Next